Roche introduces the navify brand for its digital health solutions at HLTH 2022

• Roche unifies its digital health portfolio below the navify brand, offering a spread of subsequent technology software program solutions.
• The navify portfolio makes use of digital solutions, analytics and information science to supply insights that handle right now’s real-world challenges in health, enabling assured choices and main in direction of supply of personalised healthcare.
• The navify digital solutions reinforce Roche’s dedication to assist suppliers and innovators join with sufferers for higher entry, expertise and supply of care.

BASEL, Switzerland, Nov. 4, 2022 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) introduced right now at the HLTH 2022 assembly in Las Vegas, NV, US, that its digital health portfolio will now be out there below the navify® brand. The navify digital solutions assist suppliers and sufferers ‘navigate’ and ‘make clear’ a variety of touchpoints by activating insights that present proof on methods to optimise operational processes and medical choice making in healthcare.

“Today we are using navify digital solutions, such as algorithms, and data science to deliver insights that are actionable in healthcare, building on three decades of software experience with diagnostics in laboratories,” mentioned Moritz Hartmann, Head of Roche Information Solutions. “We are creating open digital ecosystems with labs, hospitals and medtech companies to bring the latest innovations faster to society to better serve patients, and to support clinicians in providing care for patients. These activities support our strategy to deliver insights that drive personalised care.” 

Together, navify brings new methods to:

• Improve interoperability of digital infrastructure: Today restricted skills to seamlessly join and share information prices healthcare methods an est. $30 billion in the US alone,¹
• Use superior analytics to ship operational excellence, improved workflows, and patient-centric methods of working: A worldwide scarcity of as much as 15 million healthcare employees is predicted by 2030:² suppliers face growing workloads with much less assets – discovering extra efficiencies is a precedence,
• Generate superior medical insights that increase medical choice help: 2 in 3 physicians are uncertain if they’re over- or underusing diagnostics, in comparison with their friends.³

Navify helps Roche’s 125-year dedication to ship pioneering science that helps healthcare organisations enhance affected person health by advancing diagnostics, therapies and medical data. It additionally aligns with Roche’s 10-year ambition to construct a number one, worthwhile insights business.

About navify

The portfolio throughout Roche contains greater than 30 digital solutions⁴ for labs, hospitals and sufferers worldwide and plenty of key initiatives to advance digital transformation in healthcare. Several late stage pilots⁵ with prospects and tech collaborators are underway for digital infrastructure (navify Core Integrator), operational excellence (navify Sample Tracking) and for medical insights (navify Screening for Cervical Cancer, navify Kidney Companion and navify Algorithm Suite).

With navify Marketplace, Roche connects labs and healthcare suppliers and third-party medtech and different corporations to assist carry improvements to healthcare. Several startups or corporations are concerned and extra are becoming a member of:  Smart4Diagnostics, imito (wound.app), determine Clinical Software (glucotab), Glytec, Precordior (CardioSignal), SteadySense (SteadyTemp), Deigma, TestCard, Etheclo, Tracie Healthcare Solutions and Binary Tech. Medial EarlySign, which develops AI-based medical predictive analytics, is the newest to affix, permitting for EarlySign ColonFlag⁶ to be accessible to labs and hospitals through the navify platform in the close to future. 

Information about navify is obtainable at navify.com. 

About Roche’s presence at HLTH 2022

James Musick, Global Head of Personalised Healthcare at Roche, will current on Tuesday, 15 November at 3:30 PM PT on the Seaport Stage. He will talk about how right now’s convergence of pioneering science, know-how, and information is driving new patient-centred healthcare solutions which can be unlocking sustainable and widespread entry to personalised healthcare.

navify solutions highlighted at Roche’s sales space throughout HLTH 2022 embrace:

• navify digital infrastructure solutions to securely combine information throughout care settings and Roche’s open digital ecosystems to speed up innovation in care settings,
• navify operational excellence solutions to drive efficiencies, increase health fairness and allow worth primarily based care in labs and level of care (e.g. Viewics LabOps Suite, cobas infinity edge SMART, navify Sample Tracking manages samples earlier than reaching labs),
• navify medical insights’ solutions utilizing superior analytics, algorithms to show information into insights that increase clinicians’ potential to enhance care (e.g. navify Oncology portfolio, navify Diagnostic Optimization, navify Infection Management, navify Algorithm Suite, and navify Kidney Companion).

The Roche presence at HLTH additionally contains 10 in-booth talks, resembling:

• Open Digital Ecosystem & the Future of Healthcare
• Transforming Healthcare Together
• navify Oncology portfolio
• Innovating point-of-care testing

About Roche 

Founded in 1896 in Basel, Switzerland, as one in every of the first industrial producers of branded medicines, Roche has grown into the world’s largest biotechnology firm and the world chief in in-vitro diagnostics. The firm pursues scientific excellence to find and develop medicines and diagnostics for bettering and saving the lives of individuals round the world. We are a pioneer in personalised healthcare and wish to additional remodel how healthcare is delivered to have an excellent better impression. To present the greatest care for every individual we associate with many stakeholders and mix our strengths in Diagnostics and Pharma with information insights from the medical observe.

In recognising our endeavour to pursue a long-term perspective in all we do, Roche has been named one in every of the most sustainable corporations in the prescribed drugs trade by the Dow Jones Sustainability Indices for the thirteenth consecutive 12 months. This distinction additionally displays our efforts to enhance entry to healthcare along with native companions in each nation we work.

Genentech, in the United States, is a completely owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For extra info, please go to www.roche.com.

All emblems used or talked about on this launch are protected by legislation.

References

For additional info please contact

Christine Englund, Head Provider Insights Communications, Roche Information Solutions

Phone: +1 669 301 8709

e-Mail: [email protected]

Monica Ryser, Head Lab Insights Communications, Roche Information Solutions

Phone: +41 79 638 9492

e-Mail: [email protected]

Photo – https://mma.prnewswire.com/media/1937602/navify_Graphic.jpg

View authentic content material:https://www.prnewswire.co.uk/news-releases/roche-introduces-the-navify-brand-for-its-digital-health-solutions-at-hlth-2022-301668454.html

Source link